IIM
ANIK icon

Ironwood Investment Management’s Anika Therapeutics ANIK Stock Holding History

Ironwood Investment Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$951K Sell
65,567
-43
-0.1% -$499 0.4% 78
2025
Q4 		$631K Buy
65,610
+37,413
+133% +$358K 0.27% 103
2025
Q3 		$265K Sell
28,197
-164
-0.6% -$1.57K 0.12% 139
2025
Q2 		$300K Buy
28,361
+1,511
+6% +$19.1K 0.15% 126
2025
Q1 		$404K Buy
26,850
+1,186
+5% +$19.7K 0.22% 112
2024
Q4 		$422K Sell
25,664
-3,394
-12% -$66.9K 0.21% 111
2024
Q3 		$718K Buy
29,058
+354
+1% +$9.18K 0.35% 83
2024
Q2 		$727K Buy
28,704
+15,032
+110% +$390K 0.39% 82
2024
Q1 		$347K Sell
13,672
-99
-0.7% -$2.4K 0.17% 127
2023
Q4 		$312K Buy
+13,771
New +$285K 0.16% 128

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Ironwood Investment Management's ANIK Position: Q1 2026 in Review

Ironwood Investment Management reduced its Anika Therapeutics (ANIK) stake by 0.07% in Q1 2026, selling an estimated $499 and leaving 65,567 shares worth $951K. The position accounts for 0.4% of the portfolio, ranked #78.

Ironwood Investment Management first reported a position in ANIK in Q4 2023 and has held it in 10 quarters since. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.

  • Ironwood Investment Management held 65,567 shares of Anika Therapeutics worth $951K as of Q1 2026.
  • Ironwood Investment Management sold 43 Anika Therapeutics shares in Q1 2026, an estimated $499.
  • Anika Therapeutics made up 0.4% of Ironwood Investment Management's portfolio in Q1 2026, its #78 holding.
  • Ironwood Investment Management first reported a position in Anika Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.

Based on Ironwood Investment Management's 13F filing for Q1 2026, filed 15 May 2026.